Seer, Inc. will announce Q2 2025 financial results on August 6, 2025, with a webcast at 1:30 PM PT.
Quiver AI Summary
Seer, Inc. announced that it will release its financial results for the second quarter of 2025 on August 6, 2025, with a conference call scheduled for 1:30 p.m. Pacific Time. The call will be webcast live on the Investor section of their website, where an archived replay will also be available afterward. Seer, a leader in deep proteomics, develops innovative solutions that overcome the limitations of traditional proteomic technologies, offering unprecedented scale, speed, precision, and reproducibility. Their Proteograph Product Suite utilizes advanced techniques to provide insights into biological data, although the products are intended for research use only and not for diagnostic purposes. For more details, visit Seer's website.
Potential Positives
- Seer is set to report its financial results for the second quarter of 2025, indicating transparency and ongoing communication with investors.
- The company will host a conference call to discuss these results, allowing for direct engagement with stakeholders.
- Seer continues to position itself as a leader in the proteomics field by emphasizing the unique capabilities and advantages of its Proteograph Product Suite, which addresses common challenges in traditional proteomic research.
Potential Negatives
- None
FAQ
When will Seer, Inc. release its Q2 2025 financial results?
Seer, Inc. will report its financial results for the second quarter 2025 on Wednesday, August 6, 2025.
What time is the conference call for Seer's financial results?
The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
How can I access the live webcast of Seer's conference call?
The live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio.
Will there be a replay of the conference call available?
Yes, an archived replay of the conference call will be available on the company’s website following the event.
What does Seer, Inc. specialize in?
Seer, Inc. specializes in deep, unbiased proteomics, providing unprecedented insights with unique technologies.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SEER Insider Trading Activity
$SEER insiders have traded $SEER stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $SEER stock by insiders over the last 6 months:
- OMID FAROKHZAD (CEO AND CHAIR) has made 0 purchases and 2 sales selling 41,731 shares for an estimated $87,898.
- DIPCHAND NISHAR sold 30,253 shares for an estimated $62,935
- DAVID R. HORN (PRESIDENT & CFO) has made 0 purchases and 2 sales selling 10,310 shares for an estimated $21,967.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SEER Hedge Fund Activity
We have seen 22 institutional investors add shares of $SEER stock to their portfolio, and 33 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TANG CAPITAL MANAGEMENT LLC removed 900,000 shares (-41.0%) from their portfolio in Q1 2025, for an estimated $1,521,000
- CITIGROUP INC removed 350,519 shares (-90.0%) from their portfolio in Q1 2025, for an estimated $592,377
- MORGAN STANLEY removed 252,886 shares (-43.3%) from their portfolio in Q1 2025, for an estimated $427,377
- JACOBS LEVY EQUITY MANAGEMENT, INC added 201,491 shares (+124.5%) to their portfolio in Q1 2025, for an estimated $340,519
- CITADEL ADVISORS LLC removed 188,976 shares (-82.1%) from their portfolio in Q1 2025, for an estimated $319,369
- TWO SIGMA INVESTMENTS, LP removed 163,865 shares (-34.9%) from their portfolio in Q1 2025, for an estimated $276,931
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 126,178 shares (+199.0%) to their portfolio in Q1 2025, for an estimated $213,240
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday, August 6, 2025. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.
About Seer
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics—delivering insights with a scale, speed, precision, and reproducibility previously unattainable. Seer’s Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer’s robust and scalable workflow consistently reveals biological insights that others cannot. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information about Seer’s differentiated approach and ongoing leadership in proteomics, visit
www.seer.bio
.
Media Contact:
Consort Partners
[email protected]
Investor Contact:
Carrie Mendivil
[email protected]
